Abstract
Studies examining GABAB receptor agonists have reported effects on sleep including decreased sleep onset latency (SOL), increased sleep consolidation and increases in slow wave sleep (SWS). γ-hydroxybutyrate (GHB) is proposed to act as a GABAB receptor agonist; however, the mechanism of action of GHB is controversial. In addition, the GABAB receptor agonist, baclofen, has also been proposed to exert similar effects on sleep. The aim of this paper is to provide a review of the human clinical studies of sodium oxybate and baclofen regarding sleep and the treatment of sleep disorders including narcolepsy and insomnia, as well as other disorders involving disrupted sleep such as fibromyalgia.
Keywords: Sodium Oxybate, Gamma Hydroxybutyrate, GHB, Xyrem, Baclofen, GABA-B, Narcolepsy, Insomnia, fibromyalgia, hyperpolarization, -butyrolactone, succinic semialdehyde, schizophrenia, Polysomnograms, triazolam, episodic, cataplexy
Current Pharmaceutical Design
Title: A Review of Sodium Oxybate and Baclofen in the Treatment of Sleep Disorders
Volume: 17 Issue: 15
Author(s): Mark A. Brown and Christian Guilleminault
Affiliation:
Keywords: Sodium Oxybate, Gamma Hydroxybutyrate, GHB, Xyrem, Baclofen, GABA-B, Narcolepsy, Insomnia, fibromyalgia, hyperpolarization, -butyrolactone, succinic semialdehyde, schizophrenia, Polysomnograms, triazolam, episodic, cataplexy
Abstract: Studies examining GABAB receptor agonists have reported effects on sleep including decreased sleep onset latency (SOL), increased sleep consolidation and increases in slow wave sleep (SWS). γ-hydroxybutyrate (GHB) is proposed to act as a GABAB receptor agonist; however, the mechanism of action of GHB is controversial. In addition, the GABAB receptor agonist, baclofen, has also been proposed to exert similar effects on sleep. The aim of this paper is to provide a review of the human clinical studies of sodium oxybate and baclofen regarding sleep and the treatment of sleep disorders including narcolepsy and insomnia, as well as other disorders involving disrupted sleep such as fibromyalgia.
Export Options
About this article
Cite this article as:
A. Brown Mark and Guilleminault Christian, A Review of Sodium Oxybate and Baclofen in the Treatment of Sleep Disorders, Current Pharmaceutical Design 2011; 17 (15) . https://dx.doi.org/10.2174/138161211796197098
DOI https://dx.doi.org/10.2174/138161211796197098 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological
Targets
Current Topics in Medicinal Chemistry The Tortuous Road to an Ideal CGRP Function Blocker for the Treatment of Migraine
Current Topics in Medicinal Chemistry Current Status of Carbapenem Antibiotics
Current Topics in Medicinal Chemistry Henoch Schonlein Purpura in Childhood
Current Pediatric Reviews Studies on the Pathophysiology and Genetic Basis of Migraine
Current Genomics Agomelatine for Bipolar Depression: A Chronotherapeutic Agent?
Current Psychopharmacology Neurokinin-1 Receptor Antagonists in Lung Cancer Therapy
Letters in Drug Design & Discovery Cerebrovascular Complications After Heart Transplantation
Current Cardiology Reviews The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Current Genomics Is Nitric Oxide Assuming a Janus-Face in The Central Nervous System?
Current Medicinal Chemistry 1, 2-Benzisoxazole: A Privileged Structure with a Potential for Polypharmacology
Current Pharmaceutical Design A Novel Work on Analyzing STRESS and Depression level of Indian Population During COVID-19
Recent Advances in Computer Science and Communications Seizures Secondary to Bupropion Misuse/Abuse: Three Cases
Adolescent Psychiatry Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic Mechanisms
Recent Patents on CNS Drug Discovery (Discontinued) Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism
Current Pharmaceutical Design The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants
Current Drug Metabolism Anticancer Activity of Ocimum basilicum and the Effect of Ursolic Acid on the Cytoskeleton of MCF-7 Human Breast Cancer Cells
Letters in Drug Design & Discovery Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Endothelin Receptor Antagonists: Another Potential Alternative for Cardiovascular Diseases
Current Drug Targets - Cardiovascular & Hematological Disorders Editorial (Thematic Issue: Myokines and Exercise Training: More Shadows than Lights)
Current Pharmaceutical Design